FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Billaud

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Physiology

Anatomy

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Valentina De Falco; Joseph M Gozgit; Magesh Muthu; Fulvio Basolo; Marc Billaud; Preziosa Buonocore; Francesca Carlomagno; Liborio Torregrossa; Massimo Santoro
Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer.
Renaud Prudent; Emmanuelle Soleilhac; Glaucio Valdameri; Jean Viallet; Émilie Vassal-Stermann; Caroline Barette; Marc Billaud; Agnès Desroches-Castan; Attilio Di Pietro; Jean-Jacques Feige; Jean-Claude Florent; Anne Martinez; Marjorie Mollaret; Chi-Hung Nguyen; Catherine Pillet; Laurence Lafanechere
Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.
Florencia Cano; Lidia M Duncan; Marc Billaud; Karine Buchet-Poyau; Helen Bye; Mark R Wills; Paul J Lehner
The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Billaud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Valentina De Falco; Joseph M Gozgit; Magesh Muthu; Fulvio Basolo; Marc Billaud; Preziosa Buonocore; Francesca Carlomagno; Liborio Torregrossa; Massimo Santoro
Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer.
The Journal of clinical endocrinology and metabolism 2013;98(5):E811-9.
2013: Renaud Prudent; Emmanuelle Soleilhac; Glaucio Valdameri; Jean Viallet; Émilie Vassal-Stermann; Caroline Barette; Marc Billaud; Agnès Desroches-Castan; Attilio Di Pietro; Jean-Jacques Feige; Jean-Claude Florent; Anne Martinez; Marjorie Mollaret; Chi-Hung Nguyen; Catherine Pillet; Laurence Lafanechere
Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.
British journal of pharmacology 2013;168(3):673-85.
2012: Florencia Cano; Lidia M Duncan; Marc Billaud; Karine Buchet-Poyau; Helen Bye; Mark R Wills; Paul J Lehner
The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation.
The EMBO journal 2012;31(17):3596-606.
2012: H Gaude; Jörg Höhfeld; P Meyer; C Perret; C Rogon; Jean-Marc Vanacker; A Vigouroux; A Woods; N Aznar; Marc Billaud; A Bres; Karine Buchet-Poyau; C Caillat; A Delay; Christelle Forcet
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
Oncogene 2012;31(12):1582-91.
2011: Marc Billaud; Massimo Santoro
Is Co-option a prevailing mechanism during cancer progression?
Cancer research 2011;71(21):6572-5.
2011: Laurent Mouchiroud; Laurent Molin; Prasad Kasturi; Mohamed N Triba; Marc-Emmanuel Dumas; Marieangela C Wilson; Andrew P Halestrap; Damien Roussel; Ingrid Masse; Nicolas Dallière; Laurent Ségalat; Marc Billaud; Florence Solari
Pyruvate imbalance mediates metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans.
Aging cell 2011;10(1):39-54.
2010: Nicolas Aznar; Marc Billaud
Primary cilia bend LKB1 and mTOR to their will.
Developmental cell 2010;19(6):792-4.
2010: Marc Billaud; Benoît Viollet
Close encounters of a novel kind: a multi-targeted cancer drug meets a metabolic sensor.
Cancer biology & therapy 2010;10(1):77-8.
2010: Luigi Alfano; Teresa Guida; Livia Provitera; Giancarlo Vecchio; Marc Billaud; Massimo Santoro; Francesca Carlomagno
RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block.
The Journal of clinical endocrinology and metabolism 2010;95(7):3552-7.
2008: Gaëlle Laurent; Florence Solari; Bogdan Mateescu; Melis Karaca; Julien Castel; Brigitte Bourachot; Christophe Magnan; Marc Billaud; Fatima Mechta-Grigoriou
Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling.
Cell metabolism 2008;7(2):113-24.
2008: Ingrid Masse; Laurent Molin; Laurent Mouchiroud; Philippe Vanhems; Francesca Palladino; Marc Billaud; Florence Solari
A novel role for the SMG-1 kinase in lifespan and oxidative stress resistance in Caenorhabditis elegans.
PloS one 2008;3(10):e3354.
2007: Christelle Forcet; Marc Billaud
Dialogue between LKB1 and AMPK: a hot topic at the cellular pole.
Science's STKE : signal transduction knowledge environment 2007;2007(404):pe51.
2007: Julien Thérier; Florence Solari; Marc Billaud
[PTEN: a guard of nuclear safety].
Médecine sciences : M/S 2007;23(5):453-4.
2007: Karine Buchet-Poyau; Julien Courchet; Hervé Le Hir; Bertrand Séraphin; Jean-Yves Scoazec; Laurent Duret; Claire Domon-Dell; Jean-Noel Freund; Marc Billaud
Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies.
Nucleic acids research 2007;35(4):1289-300.
2006: Karen Moreau; Eva Dizin; Hind Ray; Celine Luquain; Etienne Lefai; Fabienne Foufelle; Marc Billaud; Gilbert M Lenoir; Nicole Dalla Venezia
BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.
The Journal of biological chemistry 2006;281(6):3172-81.
2005: Barbara Frêche; Patricia Guillaumot; Julie Charmetant; Ludivine Pelletier; Celine Luquain; Dale Christiansen; Marc Billaud; Serge Manié
Inducible dimerization of RET reveals a specific AKT deregulation in oncogenic signaling.
The Journal of biological chemistry 2005;280(44):36584-91.
2005: Ingrid Masse; Laurent Molin; Marc Billaud; Florence Solari
Lifespan and dauer regulation by tissue-specific activities of Caenorhabditis elegans DAF-18.
Developmental biology 2005;286(1):91-101.
2005: Christelle Forcet; Sandrine Etienne-Manneville; Hélène Gaude; Laurence Fournier; Sébastien Debilly; Marko Salmi; Annette Baas; Sylviane Olschwang; Hans Clevers; Marc Billaud
Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Human molecular genetics 2005;14(10):1283-92.
2005: Florence Solari; Angélique Bourbon-Piffaut; Ingrid Masse; Bernard Payrastre; Andrew M-L Chan; Marc Billaud
The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans.
Oncogene 2005;24(1):20-7.
2004: Francesca Carlomagno; Teresa Guida; Suresh Anaganti; Giancarlo Vecchio; Alfredo Fusco; Anderson Ryan; Marc Billaud; Massimo Santoro
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.
Oncogene 2004;23(36):6056-63.
2003: Pascale Nony; Hélène Gaude; Mireille Rossel; Laurence Fournier; Jean-Pierre Rouault; Marc Billaud
Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
Oncogene 2003;22(57):9165-75.
2002: Giuliana Salvatore; Satoshi Nagata; Marc Billaud; Massimo Santoro; Giancarlo Vecchio; Ira Pastan
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase.
Biochemical and biophysical research communications 2002;294(4):813-7.
2001: Serge Manié; Massimo Santoro; Alfredo Fusco; Marc Billaud
The RET receptor: function in development and dysfunction in congenital malformation.
Trends in genetics : TIG 2001;17(10):580-9.
2001: Rosa Marina Melillo; Massimo Santoro; Sim-Heng Ong; Marc Billaud; Alfredo Fusco; YR Hadari; Joseph Schlessinger; Irit Lax
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
Molecular and cellular biology 2001;21(13):4177-87.
2001: Rosa Marina Melillo; Francesca Carlomagno; Gabriella De Vita; Pietro Formisano; Giancarlo Vecchio; Alfredo Fusco; Marc Billaud; Massimo Santoro
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
Oncogene 2001;20(2):209-18.
2000: M C Bordeaux; Christelle Forcet; L Granger; Véronique Corset; C Bidaud; Marc Billaud; Dale E Bredesen; P Edery; Patrick Mehlen
The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.
The EMBO journal 2000;19(15):4056-63.
2000: Gabriella De Vita; Rosa Marina Melillo; Francesca Carlomagno; Roberta Visconti; Maria Domenica Castellone; A Bellacosa; Marc Billaud; Alfredo Fusco; Philip Tsichlis; Massimo Santoro
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
Cancer research 2000;60(14):3727-31.
2000: C Segouffin-Cariou; Marc Billaud
Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.
The Journal of biological chemistry 2000;275(5):3568-76.
1999: Massimo Santoro; Francesca Carlomagno; Rosa Marina Melillo; Marc Billaud; Giancarlo Vecchio; Alfredo Fusco
Molecular mechanisms of RET activation in human neoplasia.
Journal of endocrinological investigation 1999;22(10):811-9.
1999: O Geneste; C Bidaud; Gabriella De Vita; R M Hofstra; S Tartare-Deckert; C H Buys; Gilbert M Lenoir; Massimo Santoro; Marc Billaud
Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
Human molecular genetics 1999;8(11):1989-99.
1999: Jean-Pierre Rouault; P E Kuwabara; O M Sinilnikova; Laurent Duret; D Thierry-Mieg; Marc Billaud
Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
Current biology : CB 1999;9(6):329-32.
1999: M Takahashi; T Iwashita; M Santoro; Stanislas LYONNET; Gilbert M Lenoir; Marc Billaud
Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Human mutation 1999;13(4):331-6.
1998: S Chappuis-Flament; A Pasini; Gabriella De Vita; C Ségouffin-Cariou; Alfredo Fusco; Tania Attié; Gilbert M Lenoir; Massimo Santoro; Marc Billaud
Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.
Oncogene 1998;17(22):2851-61.
1998: B Doray; Rémi Salomon; Jeanne Amiel; Anna Pelet; Renaud Touraine; Marc Billaud; Tania Attié; B Bachy; Arnold Munnich; Stanislas LYONNET
Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.
Human molecular genetics 1998;7(9):1449-52.
1998: Jean-Pierre Rouault; D Prévôt; Cyril Berthet; AM Birot; Marc Billaud; Jean-Pierre Magaud; Laura Corbo
Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.
The Journal of biological chemistry 1998;273(35):22563-9.
1998: Anna Pelet; O Geneste; P Edery; A Pasini; S Chappuis; T Atti; Arnold Munnich; G Lenoir; Stanislas LYONNET; Marc Billaud
Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
The Journal of clinical investigation 1998;101(6):1415-23.
1998: Francine-Marie Michiels; Marc Billaud
[The RET gene in thyroid pathology].
Archives d'anatomie et de cytologie pathologiques 1998;46(1-2):19-30.
1997: A Pasini; O Geneste; P Legrand; Martin Schlumberger; Mireille Rossel; Laurence Fournier; Brian B Rudkin; I Schuffenecker; Gilbert M Lenoir; Marc Billaud
Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.
Oncogene 1997;15(4):393-402.
1997: Francine-Marie Michiels; S Chappuis; Bernard Caillou; A Pasini; Monique Talbot; Roger Monier; Gilbert M Lenoir; Jean Feunteun; Marc Billaud
Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3330-5.
1997: Francesca Carlomagno; Giuliana Salvatore; Anna Maria Cirafici; Gabriella De Vita; Rosa Marina Melillo; Vittorio de Franciscis; Marc Billaud; Alfredo Fusco; Massimo Santoro
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
Cancer research 1997;57(3):391-5.
1997: Mireille Rossel; A Pasini; S Chappuis; O Geneste; Laurence Fournier; I Schuffenecker; M Takahashi; Leo van Grunsven; J L Urdiales; Brian B Rudkin; Gilbert M Lenoir; Marc Billaud
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.
Oncogene 1997;14(3):265-75.
1996: A Pasini; Francine-Marie Michiels; S Chappuis-Flament; O Geneste; M Rossel; Laurence Fournier; Jean Feunteun; G Lenoir; I Schuffenecker; Marc Billaud
[Neural crest and multiple endocrinopathies].
Comptes rendus des séances de la Société de biologie et de ses filiales 1996;190(5-6):557-67.
1994: I Schuffenecker; Marc Billaud; Alain Calender; B Chambe; N Ginet; C Calmettes; E Modigliani; Gilbert M Lenoir
RET proto-oncogene mutations in French MEN 2A and FMTC families.
Human molecular genetics 1994;3(11):1939-43.
1994: H Hermeking; D A Wolf; Franz Kohlhuber; A Dickmanns; Marc Billaud; Ellen Fanning; Dirk Eick
Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(22):10412-6.
1993: M Rossel; E Brambilla; Marc Billaud; Dominique A Vuitton; F Blanc-Jouvan; S Biichle; J P Revillard
Nonspecific increased serum levels of secretory component in lung tumors: relationship to the gene expression of the transmembrane receptor form.
American journal of respiratory cell and molecular biology 1993;9(3):341-6.
1993: M Cordier-Bussat; Marc Billaud; Alain Calender; Gilbert M Lenoir
Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
International journal of cancer. Journal international du cancer 1993;53(1):153-60.
1991: Ursula Zimber-Strobl; K O Suentzenich; Gerhard Laux; Dirk Eick; M Cordier; Alain Calender; Marc Billaud; Gilbert M Lenoir; Georg W Bornkamm
Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Journal of virology 1991;65(1):415-23.
1991: G Rousselet; Marc Billaud; Pierre Busson; G Lenoir; Thomas Tursz
CD23 and epithelial cells.
Monographs in allergy 1991;29():186-95.
1990: Alain Calender; M Cordier; Marc Billaud; Gilbert M Lenoir
Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).
International journal of cancer. Journal international du cancer 1990;46(4):658-63.
1990: Marc Billaud; F Rousset; Alain Calender; M Cordier; J P Aubry; V Laisse; Gilbert M Lenoir
Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
Blood 1990;75(9):1827-33.
1990: M Cordier; Alain Calender; Marc Billaud; U Zimber; G Rousselet; O Pavlish; Jacques Banchereau; Thomas Tursz; Georg W Bornkamm; Gilbert M Lenoir
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Journal of virology 1990;64(3):1002-13.
1990: G Rousselet; Pierre Busson; Marc Billaud; J M Guillon; C Scamps; H Wakasugi; G Lenoir; Thomas Tursz
Structure and regulation of the blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma.
International immunology 1990;2(12):1159-66.
1990: Ursula Zimber-Strobl; K Suentzenich; M Falk; Gerhard Laux; M Cordier; Alain Calender; Marc Billaud; Gilbert M Lenoir; Georg W Bornkamm
Epstein-Barr virus terminal protein gene transcription is dependent on EBNA2 expression and provides evidence for viral integration into the host genome.
Current topics in microbiology and immunology 1990;166():359-66.
1989: Marc Billaud; Pierre Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; Thomas Tursz; Gilbert M Lenoir
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.
Journal of virology 1989;63(10):4121-8.
1989: F Rousset; Marc Billaud; D Blanchard; Carl Figdor; G M Lenoir; H Spits; Jan E de Vries
IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(5):1490-8.
1988: Alain Calender; Marc Billaud; G Lenoir
Cooperation between cellular and Epstein-Barr virus genes in the genesis of Burkitt's lymphoma.
IARC scientific publications 1988;(92):159-64.
1987: Marc Billaud; Alain Calender; J M Seigneurin; G M Lenoir
LFA-1, LFA-3, and ICAM-1 expression in Burkitt's lymphoma.
Lancet 1987;2(8571):1327-8.
1987: Alain Calender; Marc Billaud; J P Aubry; Jacques Banchereau; M Vuillaume; Gilbert M Lenoir
Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(22):8060-4.